The novel drug delivery systems in cancer therapy market is set to witness remarkable growth, with projections indicating an increase from USD 19.6 billion in 2024 to an impressive USD 54.8 billion by 2034. This expansion is driven by a robust CAGR of 10.8% during the forecast period, fueled by the increasing demand for minimally …